Incretin-based therapy in combination with basal insulin: A promising tactic for the treatment of type 2 diabetes

Autor: Vora, J., Bain, S.C., Damci, T., Dzida, G., Hollander, P., Meneghini, L.F., Ross, S.A.

Publikováno v: In Diabetes and Metabolism February 2013 39(1):6-15

The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries

Autor: Khunti, K., Caputo, S., Damci, T., Dzida, G., Ji, Q., Kaiser, M., Karnieli, E., Liebl, A., Ligthelm, R., Nazeri, A., Orozco Beltran, D., Pan, C., Ross, S., Svendsen, A., Vora, J., Yale, J., Meneghini, L., Maran, Alberto, Raimundo, L., Artola, S., Imamoglu, S.

Publikováno v: Diabetes, Obesity and Metabolism. 14:1129-1136

Aims Evaluate the safety and efficacy of once-daily insulin detemir initiated in routine clinical practice in patients with type 2 diabetes mellitus inadequately controlled with oral hypoglycaemic agents (OHAs). Methods This large observational study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b73edfcbd98588cc3d7dd7b3735ac2b
https://doi.org/10.1111/j.1463-1326.2012.01665.x

Safety of once- daily insulin detemir in patients with type 2 diabetes treated with oral hypoglycemic agents in routine clinical practice

Autor: Ross S, Dzida G, Ji Q, Kaiser M, Ligthelm R, Meneghini L, Nazeri A, Orozco-Beltran D, Pan C, Svendsen A, SOLVE Study Grp

Publikováno v: JOURNAL OF DIABETES
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante

BackgroundThe aim of the present study was to identify demographic and treatment factors that were predictive of hypoglycemia in a large cohort of type 2 diabetic patients initiating insulin detemir. MethodsThe present 24-week observational study of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1d31b6be3e9757a437217b5641bb0b8d
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=4764

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.